Navigation Links
Volcano Announces Closing of CardioSpectra Acquisition
Date:12/18/2007

SAN DIEGO, Dec. 18 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural heart disease, announced today that it has completed its previously announced acquisition of CardioSpectra, Inc.

CardioSpectra is a privately-held company developing innovative Optical Coherence Tomography (OCT) technology. CardioSpectra's unique OCT imaging system is expected to complement Volcano's existing product offerings and further enhance Volcano's position as an imaging technology leader in the field of interventional medicine.

Under terms of the agreement, which was announced on December 10, 2007, Volcano paid $25 million in cash at closing to CardioSpectra's shareholders and warrant holders. In addition, Volcano may make additional payments upon the achievement of certain product development, regulatory and revenue milestones. Any future payment may be made in cash or stock, or a combination of both at Volcano's discretion.

About Volcano

Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including b
'/>"/>

SOURCE Volcano Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...RORA, Ontario, Nov. 6 He...: HXBPF) today announced that John Docherty, presi...Merriman Curhan Ford,s 6th annual Investor Summit ...el in New York City. Mr. Docherty will provide an...ment programs L-DOS47 and Topical Interferon Alpha...
(Date:11/6/2009)...RING VALLEY, Calif., Nov. 6 Calbio...d a Small Business Innovative Research (SBIR) Phas... Material command. Under terms of the agreement, C...ASRs) for the diagnosis of Dengue virus. ,, ...presents a major threat to military forces deploye...
(Date:11/5/2009)...NSPORTATION -- Gone hybrid . . . , Fuel econom...are now posted at the www.fueleconomy.gov web si...and maintains for the U.S. Department of Energy an...f the top 10 vehicles on the best fuel economy lis...1 MPG city; 48 highway). "This list proves that hy...
(Date:11/5/2009)...N DIEGO, Nov. 5 Imagenet...ay that William Spencer, President and CEO of Imag...the 2nd annual LD MICRO Conference on Thursday, De...Los Angeles. ,, About LD MICRO ,, LD MICRO i...s on finding undervalued companies in the micro-ca...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...12 New Delhi based Mayuka Labs,Private Limited ha...amp;,development facility from the department of s... ministry of science and technology, Government of...ound the clock at its R&D and Pilot,unit at Na...its first year of,operations. The company has file...
...w white papers detailing sterility testing essenti...test ( www.microtestlabs.com ). The white papers,...cturers and one which is specialized for pharmaceu... and problems associated with sterility testing an...r medical device manufacturers, sterility testing ...
...ista Therapeutics, Inc. (NYSE Alternext US : SY...dy, a Phase 2 double-blind, placebo-controlled, ra...m. The study is designed to measure the effect of ...chronic systolic heart failure. In addition, the C...EAK ( B eginning a R andomized E valuation of th...
Other Biology Technology:Mayuka Labs R&D Centre Gets DSIR Recognition 2Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4
(Date:11/8/2009)...due University have discovered a new approach for ...ries using nano-spheres that could be injected int...thetic "copolymer micelles" are drug-delivery sphe...0 times smaller than the diameter of a red blood c...iver drugs for cancer treatment and other therapie...
(Date:11/8/2009)...H INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR HE...olving adults with intellectual disabilities found...nowledge after taking a semi-weekly class for four...cepted term for mental retardation, have slightly ...reventable chronic diseases compared to the genera...
(Date:11/6/2009)...h of the publication of On the Origin of Species, ...S) is publishing open access two peer-reviewed art...ts into evolution. , The two articles are by Kevi..., and James T. Costa of Western Carolina Universit...in," appeared in the October issue of the AIBS jou...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Antibiotic Resistance Still a Major Public Health Threat 60427 1Antibiotic Resistance Still a Major Public Health Threat 60427 2Antibiotic Resistance Still a Major Public Health Threat 60427 3Antibiotic Resistance Still a Major Public Health Threat 60427 4Asians Seem to Suffer Less During Childbirth 60423 1Asians Seem to Suffer Less During Childbirth 60423 2
... in humans, scientists have found early indicators...-related injuries caused by repetitive motion. , ...on and prevention of debilitating conditions such ... new study from Temple University senior researche...ent, Stephen Carp, in the March issue of Clinical ...
... the Ludwig Institute for Cancer Research (LICR) a...School of Medicine have made a breakthrough in ide...according to a report published online today in Na...ify genes (the ,what,) within the genome, it canno...,when, and ,where, gene products are expressed. Ho...
...was thought to be caused by hypoglycemic coma actu...the coma, according to a study in rodents led by r... , The results are surprising, say the authors, a...nt of diabetics in hypoglycemic coma, though they ...rapolated to humans. , Insulin is an essential ...
Other Biology News:Red flag for repetitive stress injuries identified for first time in humans 2Beyond the DNA: Chemical signatures reveal genetic switches in the genome 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3
...gands\n\nReceptor-related research has long been e...abeled ligands selected to keep pace with new disc...ts and services for receptor research and drug dis...igands. If you do not find exactly what you need, ...
...ve and specific detection of microRNAs (miRNAs) by...ave high binding affinity and discrimination, enab...s. Due to the high binding affinity of the miRCURY... needed compared to traditional probes. Furthermor...
Rabbit Anti-Mouse Vitronectin Polyclonal Antibody, Unconjugated from Abcam
...methylation is an irreversible post translational ...o protein activity. At least three types of PRMT e...ese enzymes have been shown to have essential regu... several fundamental areas. These protein include ...
Biology Products: